4.6 Article

Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial

Katharina Mayer et al.

Summary: The study aimed to evaluate a novel antithrombotic drug, revacept, which failed to reduce myocardial injury in patients with stable ischemic heart disease undergoing percutaneous coronary intervention. There were few bleeding events and no significant differences between treatment arms.

JAMA CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

2018 ESC/EACTS Guidelines on myocardial revascularization

Franz-Josef Neumann et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention

Gjin Ndrepepa et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Medicine, General & Internal

Procedure-related bleeding in elective percutaneous coronary interventions

Gjin Ndrepepa et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Cardiac & Cardiovascular Systems

Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

Udaya S. Tantry et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Article Medical Laboratory Technology

Sandwich Immunoassay for Soluble Glycoprotein VI in Patients with Symptomatic Coronary Artery Disease

Boris Bigalke et al.

CLINICAL CHEMISTRY (2011)

Review Pharmacology & Pharmacy

Platelet and Soluble Glycoprotein VI - Novel Applications in Diagnosis and Therapy

Boris Bigalke et al.

CURRENT DRUG TARGETS (2011)

Article Cardiac & Cardiovascular Systems

Glycoprotein VI for diagnosis of acute coronary syndrome when ECG is ambiguous

Boris Bigalke et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Glycoprotein VI as a prognostic biomarker for cardiovascular death in patients with symptomatic coronary artery disease

Boris Bigalke et al.

CLINICAL RESEARCH IN CARDIOLOGY (2010)

Article Cell Biology

Measuring soluble platelet glycoprotein VI in human plasma by ELISA

Mohammad Al-Tamimi et al.

PLATELETS (2009)

Article Cardiac & Cardiovascular Systems

Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome

Boris Bigalke et al.

AMERICAN HEART JOURNAL (2008)

Article Cardiac & Cardiovascular Systems

Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome

Boris Bigalke et al.

EUROPEAN HEART JOURNAL (2006)